Promoting patient-centered drug development from a regulatory perspectiveDONG Li-juan, SUN Li-hua897-902
Patent analysis of 5-HT1F receptor agonists for the treatment of migraineKANG Peng-cheng, WU Ya-nan903-910
International status of orphan drug registration review system and the enlightenment to ChinaYANG Run-feng, WANG Qian, TIAN Kan911-917
Olanzapine/samidorphan:a new synthetic agent for the treatment of schizophrenia and bipolar I disorderWU Qi, ZHANG Xiao-juan, ZHANG Hong-qiang918-921
The FDA's regulation of premarket approval in cross-labeled combination productsJIANG Jian-ping, SHAO Ying922-932
Bioequivalence study of calcium dobesilate capsules in Chinese healthy subjectsZHANG Wen-rui, WEN Xiao-qing, LUO Xi, LIU Jian-feng933-938
A randomized,parallel-controlled clinical study of Tibetan medicine in the treatment of COVID-19 infection in plateau regionGESANG Yun-dan, DUO Jie-tai, ZHANG Qiong-wen, PINGCUO Duo-ji, WANG Bao, SUOLANG Ren-qing, SANG Dan, SHEN Yan-ru, LI Yan-jun, MINGJI Cuo-mu, DANSONG Zha-ba, TANG Jian-yuan, CHEN Wei-wu939-945
A data-driven dynamic evaluation model for the quality management level of clinical trial institutionsDONG Wen-bin, JIANG Min, ZHAO Shu-hua, ZHANG Xue-mei, CHEN Yi-fei946-952
Construction and application of clinical research data standard for lymphomaMI Lan, XIE Yan, HOU Yan, WANG Wei-yu, ZHU Jun, SONG Yu-qin953-960
Optimization of extraction process of Yinqi Qingwen Formula based on network pharmacology combined with entropy weight analysisZHANG Ya-xuan, YUAN Rui, SHEN Hui-juan, ZHONG Wan-ling, FAN Xiao-yu, YE Jin-hong, MA Yun-nan, BAI Jie, DU Shou-ying961-972